About CHU Brabois
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Central Hospital, Nancy, France
46
The Lymphoma Academic Research Organisation
25
Groupe Francophone des Myelodysplasies
22
Janssen Research & Development, LLC
12
Hoffmann-La Roche
10
French Innovative Leukemia Organisation
8
Celgene
7
UNICANCER
7
Eli Lilly and Company
6
Federation Francophone de Cancerologie Digestive
6
Hospices Civils de Lyon
6
Clinical Trials at CHU Brabois
During the past decade, CHU Brabois conducted 202 clinical trials. In the 10-year time frame, 202 clinical trials started and 40 clinical trials were completed, i.e. on
average, 19.8% percent of trials that started reached the finish line to date. In the past 5 years, 88 clinical trials started and 21 clinical trials were completed. i.e. 23.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
1993-03-01
Unknown status
280
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1994-12-01
2002-01-01
Completed
180
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
1998-08-01
Completed
450
Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
1993-07-01
Unknown status
350
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
1998-09-01
2005-09-01
Completed
36
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CHU Brabois" #1 sponsor was "Central Hospital, Nancy, France" with 46 trials, followed by "The Lymphoma Academic Research Organisation" with 25 trials
sponsored, "Groupe Francophone des Myelodysplasies" with 22 trials sponsored, "Janssen Research & Development, LLC" with 12 trials sponsored and "Hoffmann-La Roche"
with 12 trials sponsored. Other sponsors include 231 different institutions and
companies that sponsored additional 126 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Brabois"
#1 collaborator was "Novartis" with 8 trials as a collaborator, "Celgene Corporation" with 6 trials as a collaborator, "AbbVie" with 5 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator and "Janssen-Cilag Ltd." with 4 trials as a collaborator. Other collaborators include 161 different institutions and companies that were
collaborators in the rest 138 trials.
Clinical Trials Conditions at CHU Brabois
According to Clinical.Site data, the most researched conditions in "CHU Brabois" are
"Myelodysplastic Syndromes" (15 trials), "Ulcerative Colitis" (13 trials), "Crohn's Disease" (11 trials), "Multiple Myeloma" (11 trials) and "Acute Myeloid Leukemia" (10 trials). Many other conditions were trialed in "CHU Brabois" in a lesser frequency.
Clinical Trials Intervention Types at CHU Brabois
Most popular intervention types in "CHU Brabois" are "Drug" (229 trials), "Other" (51 trials), "Procedure" (36 trials), "Device" (28 trials) and "Biological" (27 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (44 trials), "Lenalidomide" (14 trials), "Rituximab" (14 trials), "Dexamethasone" (11 trials) and "Cyclophosphamide" (10 trials). Other intervention names were less common.
Clinical Trials Genders at CHU Brabois
The vast majority of trials in "CHU Brabois" are
345 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at CHU Brabois
Currently, there are 130 active trials in "CHU Brabois".
10 are not yet recruiting,
78 are recruiting,
41 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 166 completed trials in CHU Brabois,
undefined suspended trials,
and 18 terminated clinical trials to date.
Out of the total trials that were conducted in CHU Brabois, 18 "Phase 1"
clinical trials were conducted, 113 "Phase 2" clinical
trials and 112 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 16 trials, and there were
also 58 trials that are defined as “Not Applicable".